Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kowalyszyn RD"'
Autor:
Borghaei H; Fox Chase Cancer Center, Philadelphia, USA. Electronic address: Hossein.Borghaei@fccc.edu., O'Byrne KJ; Princess Alexandra Hospital and Queensland University of Technology, Brisbane, Australia., Paz-Ares L; Hospital Universitario 12 de Octubre, Universidad Complutense & CiberOnc, Madrid, Spain., Ciuleanu TE; Institutul Oncologic Prof. Dr. Ion Chiricuţă and UNF Iuliu Haţieganu University, Cluj-Napoca, Romania., Yu X; Zhejiang Cancer Hospital, Hangzhou, China., Pluzanski A; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Nagrial A; Blacktown Hospital, Sydney, Australia., Havel L; Thomayer Hospital, Charles University, Prague, Czech Republic., Kowalyszyn RD; Clínica Viedma, Viedma, Argentina., Valette CA; Hôpital Sainte -Musse, Toulon, France., Brahmer JR; Johns Hopkins, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA., Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany., Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, USA., Zhang L; Sun Yat-Sen University Cancer Center, Guangdong, China., Ntambwe I; Bristol Myers Squibb, Princeton, USA., Rabindran SK; Bristol Myers Squibb, Princeton, USA., Nathan FE; Bristol Myers Squibb, Princeton, USA., Balli D; Bristol Myers Squibb, Princeton, USA., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong, China.
Publikováno v:
ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102065. Date of Electronic Publication: 2023 Nov 20.
Autor:
Rugo HS; University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Umanzor GA; Centro Oncológico Integral with DEMEDICA, San Pedro Sula, Honduras., Barrios FJ; American Cancer Center, Guatemala City, Guatemala., Vasallo RH; Clinical Research RD, Santo Domingo, Dominican Republic., Chivalan MA; CELAN Clínica Médica, Guatemala City, Guatemala., Bejarano S; Excel Medica, San Pedro Sula, Honduras., Ramírez JR; Sanatorio Centro Regional de Sub-Especialidades Médicas (CRESEM), Quetzaltenango, Guatemala., Fein L; Instituto de Oncología de Rosario, Rosario, Argentina., Kowalyszyn RD; Centro de Investigaciones Clínicas, Clínica Viedma, Viedma, Argentina., Kramer ED; Athenex, Inc, Buffalo, NY., Wang H; Athenex, Inc, Buffalo, NY., Kwan MR; Athenex, Inc, Buffalo, NY., Cutler DL; Athenex, Inc, Buffalo, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 01; Vol. 41 (1), pp. 65-74. Date of Electronic Publication: 2022 Jul 20.
Autor:
Kowalyszyn RD; Centro De Investigaciones Clínicas Clínica Viedma S A, Viedma, Argentina., Fein LE; Instituto Oncológico de Rosario, Rosario, Argentina., Richardet ME; Sanatorio Aconcagua, Córdoba, Argentina., Varela MS; COIBA, Berazategui, Buenos Aires, Argentina., Ortiz E; Centro Oncológico Infinito, Santa Rosa, La Pampa, Argentina., Micheri C; Instituto de Oncológico de Rosario, Rosario, Santa Fé, Argentina., Zarba JJ; Centro Medico San Roque, Tucumán, Argentina., Kahl S; Centro Investigación Pergamino, Pergamino, Buenos Aires, Argentina., Klimovsky E; QUID LATAM Consulting SRL, CABA, Argentina., Federico AA; QUID LATAM Consulting SRL, CABA, Argentina., Cassini JH; Hospital Aeronautico Central, CABA, Argentina., Cortese G; Hospital de Clínicas 'José de San Martín,' CABA, Argentina., Lago N; Gema Biotech SAU, CABA, Argentina.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2022 Mar; Vol. 8, pp. e2100276.
Autor:
Ramalingam SS; Emory University School of Medicine, Winship Cancer Institute of Emory University, Clifton Campus, Atlanta, GA. Electronic address: ssramal@emory.edu., Pérol M; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Reck M; LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Wöhrendamm, Grosshansdorf, Germany., Kowalyszyn RD; Centro de Investigaciones Clínicas, Instituto Multidisciplinario de Oncología, Clínica Viedma, Río Negro, Argentina., Gautschi O; Luzemer Kantonsspital, Luzern, Switzerland., Kimmich M; Klinik Schillerhöhe, Gerlingen, Germany., Cho EK; Hematology-Oncology Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea., Czyzewicz G; Department of Chemotherapy, John Paul II Hospital, Krakow, Poland., Grigorescu A; Department of Medical Oncology, Institute of Oncology, Bucharest, Romania., Karaseva N; City Clinical Oncology Dispensary, St Petersburg, Russian Federation., Dakhil S; Cancer Center of Kansas, Wichita, KS., Lee P; Eli Lilly and Company, Indianapolis, IN., Zimmerman A; Eli Lilly and Company, Indianapolis, IN., Sashegyi A; Eli Lilly and Company, Indianapolis, IN., Alexandris E; Eli Lilly and Company, Indianapolis, IN., Carter GC; Eli Lilly and Company, Indianapolis, IN., Winfree KB; Eli Lilly and Company, Indianapolis, IN., Garon EB; David Geffen School of Medicine at UCLA/TRIO-US Network, Los Angeles, CA.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2018 May; Vol. 19 (3), pp. 270-279.e3. Date of Electronic Publication: 2017 Dec 21.
Autor:
Paz-Ares LG; Hospital Universitario Doce de Octubre, Madrid, Spain. Electronic address: lpazaresr@seom.org., Pérol M; Département de Cancérologie Médicale, Centre Léon Bérard, Lyon, France., Ciuleanu TE; Institute of Oncology Prof. Dr. Ion Chiricuţă and University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania., Kowalyszyn RD; Centro de Investigaciones Clínicas, Clínica Viedma, Argentina., Reck M; LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany., Lewanski CR; Charing Cross Hospital, London, UK., Syrigos K; Oncology Unit GPP, Sotiria General Hospital, Athens School of Medicine, Athens, Greece., Arrieta O; Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Prabhash K; Tata Memorial Centre, Mumbai, India., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Pikiel J; Wojewódzkie Centrum Onkologii, Gdańsk, Poland., Göksel T; Ege University Faculty of Medicine, Izmir, Turkey., Lee P; Eli Lilly and Company, Bridgewater, NJ, USA., Zimmermann A; Eli Lilly and Company, Indianapolis, IN, USA., Carter GC; Eli Lilly and Company, Indianapolis, IN, USA., Alexandris E; Eli Lilly and Company, Bridgewater, NJ, USA., Garon EB; David Geffen School of Medicine at UCLA/Translational Research in Oncology-US Network, Los Angeles, CA, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2017 Oct; Vol. 112, pp. 126-133. Date of Electronic Publication: 2017 Jun 03.
Autor:
Pérol M; Léon-Bérard Cancer Centre, Lyon, France. Electronic address: maurice.perol@lyon.unicancer.fr., Ciuleanu TE; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. Electronic address: tudor@iocn.ro., Arrieta O; Instituto Nacional de Cancerologia, Mexico City, Mexico. Electronic address: cogar@servidor.unam.mx., Prabhash K; Tata Memorial Hospital, Mumbai, India. Electronic address: kprabhash1@gmail.com., Syrigos KN; Oncology Unite GPP, Sotiria General Hospital, Athens, Greece. Electronic address: ksyrigos@med.uoa.gr., Goksel T; Ege University School of Medicine, Izmir, Turkey. Electronic address: tuncaygoksel@gmail.com., Park K; Samsung Medical Center, Seoul, South Korea. Electronic address: keunchil.park@samsung.com., Kowalyszyn RD; Centro de Investigaciones Clínicas, Clínica Viedma, S.A., Argentina. Electronic address: kowar@rnonline.com.ar., Pikiel J; Wojewodzkie Centrum Onkologii, Gdansk, Poland. Electronic address: joanna.pikiel@post.pl., Lewanski CR; Charing Cross Hospital, London, UK. Electronic address: Conrad.lewanski@imperial.nhs.uk., Thomas M; Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany. Electronic address: michael.thomas@med.uni-heidelberg.de., Dakhil S; Cancer Center of Kansas, Wichita, KS, USA. Electronic address: shaker.dakhil@cancercenterofkansas.com., Kim JH; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea. Electronic address: kjhang@yuhs.ac., Karaseva N; City Clinical Oncology Dispensary, St. Petersburg, Russia. Electronic address: nkaraseva06@mail.ru., Yurasov S; Eli Lilly and Company, Bridgewater, NJ, USA. Electronic address: sergey.yurasov@imclone.com., Zimmermann A; Eli Lilly and Company, Indianapolis, IN, USA; LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, Germany. Electronic address: zimmermann_annamaria_hayden@lilly.com., Lee P; LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany. Electronic address: pablo.lee@imclone.com., Carter GC; Eli Lilly and Company, Indianapolis, IN, USA; LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, Germany., Reck M; LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany. Electronic address: M.Reck@lungenclinic.de., Cappuzzo F; Istituto Toscano Tumori, Livorno, Italy. Electronic address: f.cappuzzo@googlemail.com., Garon EB; David Geffen School of Medicine at UCLA/Translational Research in Oncology-US Network, Los Angeles, CA, USA. Electronic address: egaron@mednet.ucla.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2016 Mar; Vol. 93, pp. 95-103. Date of Electronic Publication: 2016 Jan 19.
Autor:
Garon EB; David Geffen School of Medicine at UCLA/Translational Research in Oncology-US Network, Los Angeles, CA, USA. Electronic address: egaron@mednet.ucla.edu., Ciuleanu TE; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania., Arrieta O; Instituto Nacional de Cancerologia (INCAN), Mexico City, Mexico., Prabhash K; Tata Memorial Centre, Mumbai, India., Syrigos KN; Oncology Unit GPP, Sotiria General Hospital, Athens School of Medicine, Athens, Greece., Goksel T; Ege University School of Medicine, Izmir, Turkey., Park K; Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Gorbunova V; Department of Chemotherapy, N N Blokhin Cancer Research Center, Moscow, Russia., Kowalyszyn RD; Centro de Investigaciones Clínicas, Clínica Viedma, Argentina., Pikiel J; Wojewódzkie Centrum Onkologii, Gdansk, Poland., Czyzewicz G; Chemotherapy Department, John Paul II Hospital, Krakow, Poland., Orlov SV; Pavlov State Medical University, St Petersburg, Russia., Lewanski CR; Charing Cross Hospital, London, UK., Thomas M; Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany., Bidoli P; Medical Oncology, San Gerardo Hospital, Monza, Italy., Dakhil S; Cancer Center of Kansas, Wichita, KS, USA., Gans S; St Jansdal Hospital, Herderwijk, Netherlands., Kim JH; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea., Grigorescu A; Department of Medical Oncology, Institute of Oncology, Bucharest, Romania., Karaseva N; City Clinical Oncology Dispensary, St Petersburg, Russia., Reck M; LungenClinic Grosshansdorf, German Center for Lung Research (DZL), Grosshansdorf, Germany., Cappuzzo F; Istituto Toscano Tumori, Livorno, Italy., Alexandris E; ImClone Systems, Eli Lilly, Bridgewater, NJ, USA., Sashegyi A; Eli Lilly, Indianapolis, IN, USA., Yurasov S; ImClone Systems, Eli Lilly, Bridgewater, NJ, USA., Pérol M; Léon-Bérard Cancer Centre, Lyon, France.
Publikováno v:
Lancet (London, England) [Lancet] 2014 Aug 23; Vol. 384 (9944), pp. 665-73. Date of Electronic Publication: 2014 Jun 02.